"I will grab a random book or one that I know and have read before and run through it a bit," Kelsey Grammer tells us. John Russo; Amazon Page Six may be compensated and/or receive an affiliate ...

Simpson, NASDAQ: RGNX) for RGX-121 (clemidsogene lanparvovec), a potential first-in-class, investigational gene therapy for the treatment of Mucopolysaccharidosis II (MPS II). The FDA granted ...

Simpson, NASDAQ: RGNX) for RGX-121 (clemidsogene lanparvovec), a potential first-in-class, investigational gene therapy for the treatment of Mucopolysaccharidosis II (MPS II). The FDA granted ...

Nothing says ‘summer’s here!’ than reading near a body of water. Here are 30 new books you need to read this season.

Simpson, NASDAQ: RGNX) for RGX-121 (clemidsogene lanparvovec), a potential first-in-class, investigational gene therapy for the treatment of Mucopolysaccharidosis II (MPS II). The FDA granted ...

Now, one journalist who claims to be getting to the bottom of the scandal in a new book is facing criticism for his participation in it. CNN anchor Jake Tapper has co-authored a new book ...

The book is based on more than 200 interviews, mostly with Democratic insiders, almost all of which occurred after the 2024 election was over. According to the report, Biden aides believed it was ...

Many women ‘just don’t want to’ have kids. These books don’t blame them.

Add articles to your saved list and come back to them any time. This week’s book reviews traverse the genres, from a First Nations romcom to a dystopian vision, a guide to having an open ...

A forthcoming book by two political reporters claims to reveal extensive details about the physical and cognitive decline of former President Joe Biden and what the authors describe as a concerted ...

When Jamestown residents, Rev. Wayne and Joan Eppehimer, were married back in 1980 they had never even heard of mucopolysaccharidosis (MPS). They only knew that Eppehimer had something called Hunter ...

A Prescription Drug User Fee Act target date of November 9, 2025 has been set for the application. The Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License ...